Updated 22 October 2026. General health information, not a diagnosis or a substitute for personal medical care.
Dengue is a mosquito-borne viral infection that can look like an ordinary fever at first. Most people recover, but a small proportion develop a dangerous illness that needs hospital treatment. This guide explains how to recognize that change, understand the purpose of different blood tests, and organize safer care without relying on a platelet number or an internet remedy. [1]
Recognize warning signs before looking at the numbers
A fever accompanied by headache, pain behind the eyes, muscle or joint pain, nausea, vomiting, or a rash can fit dengue, but the pattern is not unique to it. CDC explains that about one in four infected people becomes ill, and about one in twenty people who become ill develops severe dengue. Those figures describe groups, not an individual forecast. Someone whose first day seems mild still needs clear return instructions. Warning signs often emerge during the first day or two after the fever disappears, so the thermometer alone is not a reliable safety check. Seek medical attention immediately for abdominal pain or tenderness, repeated vomiting, bleeding from the nose or gums, blood in vomit or stool, or unusual exhaustion and restlessness. Do not turn a published vomiting threshold into a reason to wait while a person is deteriorating. [2]
Breathing quickly or struggling to breathe, collapse, or being difficult to wake should be treated as an emergency rather than a routine follow-up problem. If severe symptoms appear while travelling, go to a hospital promptly instead of trying to finish the holiday or wait until the flight home. Use the local emergency number when necessary. A person who is faint, confused, or seriously unwell should not drive themselves. Tell the receiving team where they have travelled and that dengue is suspected, and bring available medicines and test reports. A family member can make the call and gather documents while help is arranged; collecting a perfect record must not delay departure. The same urgency applies when the temperature has returned to normal and everyone had expected the illness to be over. [3]
Why dengue can become dangerous as fever settles
Clinicians describe febrile, critical, and recovery phases. Fever commonly lasts two to seven days. The critical phase starts around defervescence, which means the fever is subsiding, and usually lasts twenty-four to forty-eight hours. Most patients improve at this stage. In some, however, fluid leaks from small blood vessels into surrounding spaces, reducing effective circulation and potentially causing shock. A person can initially look reasonably well despite early circulatory problems. Severe dengue can involve serious plasma leakage, major bleeding, or significant organ involvement; it is not defined by a low platelet count alone. This is why a clinician evaluates the whole person and the direction of change. The timetable is a guide, not a schedule that every patient follows exactly, and new symptoms deserve attention even outside an expected day range. [4]
A useful way to understand fluid leakage is to distinguish fluid in the body from fluid in the circulation. Someone can have fluid collecting around the lungs or in the abdomen while the bloodstream is not supporting the organs adequately. Later, during recovery, previously leaked fluid moves back into circulation. Singapore government guidance highlights that this return can sometimes contribute to fluid overload. That changing balance explains why a hospital team adjusts fluids instead of using one fixed amount throughout the illness. It also explains why new breathlessness is not a signal to make someone drink as much as possible. It is a reason for prompt assessment. Families do not need to calculate this balance themselves; they need to notice a change and report it accurately, including whether breathing or swelling has changed since the last review. [5]
| Situation | What it does not prove | Safer response |
|---|---|---|
| The fever is lower | That the danger has passed | Continue the agreed monitoring and watch for warning signs. |
| An early dengue test is negative | That dengue is excluded | Ask which test was used and whether follow-up testing is needed. |
| The platelet count is low | That transfusion is automatically required | Let the treating team interpret the count with symptoms and other findings. |
| The patient is vomiting or breathless | That more fluids at home will solve the problem | Seek urgent reassessment rather than forcing drinks. |
What causes dengue, and can you get it again?
Dengue is caused by four related virus types, often written DENV-1 through DENV-4. Singapore’s Communicable Diseases Agency describes transmission through the bite of an infected Aedes mosquito and recognizes that infection can happen more than once. Knowing the name of the virus type is usually less useful for a household than knowing the illness day, symptoms, and review plan. Dengue is not a condition restricted to one age group or to people with a particular lifestyle. Living in or visiting an affected area creates exposure opportunities. A history of mosquito bites may support the story, but people do not always remember a bite. Equally, having a rash or finding mosquitoes nearby does not establish the diagnosis. These are details to share with the clinician, not a replacement for clinical assessment and appropriately timed testing. [6]
An earlier dengue infection generally provides long-lasting protection against that same virus type, but protection against the other types is limited. A second infection carries a higher risk of severe disease, yet severe dengue can also occur during a first or later infection. It is therefore inaccurate to say that a second infection will inevitably be severe, or that a first episode is automatically harmless. Keep a copy of a previous confirmed diagnosis if you have one, and mention it at future appointments. Do not assume that a childhood illness described as dengue was laboratory-confirmed unless records support that. The distinction matters particularly when a clinician considers vaccination. Previous infection changes the discussion, but the response to current warning signs remains the same: prompt care, regardless of how many episodes someone thinks they have had. [7]
The usual transmission cycle runs from an infected person to a mosquito and then from an infected mosquito to another person. Aedes mosquitoes can live inside and outside homes and can bite during the day and at night. They often breed around water-holding containers, rather than needing a large swamp or an obviously dirty neighbourhood. Ordinary companionship is not the main transmission route, so a sick family member needs care and mosquito protection, not social exclusion. Less common routes include infected blood or tissues and transmission during pregnancy or around birth. CDC also notes that breastfeeding transmission has not been confirmed and encourages breastfeeding because of its benefits and the low potential transmission risk. A mother who is unwell should discuss her own care and her baby’s feeding needs with the treating team rather than abruptly stopping feeds based on fear. [8]
Do not diagnose every travel fever as dengue
Dengue can affect infants, children, and adults, and symptoms can vary between these groups. NSW Health notes that serious complications can include plasma leakage, respiratory distress, bleeding, and organ impairment. The practical lesson is that neither age nor a familiar-looking rash reliably tells you how serious an illness is. Describe what you can observe: when fever started, whether the person can drink, how alert they are, whether urine output has changed, and whether any bleeding has occurred. Avoid trying to reproduce a clinical tourniquet test or judging severity from a photograph of a rash. A photograph can help document a change for a clinician, but the person’s condition takes priority. New bleeding spots are a reason to mention the finding clearly, not a reason to decide the cause at home. [9]
Dengue, chikungunya, Zika, and other infections can overlap in their early presentation, and more than one may be circulating in the same location. WHO’s integrated arboviral guidance emphasizes this diagnostic difficulty. A symptom such as joint pain does not sort these infections reliably on its own. The clinician may need to consider several possibilities and choose tests based on travel, local circulation, pregnancy, and the day symptoms started. Let them know about relevant vaccination and past infection history as well. If the working diagnosis changes after testing, that does not necessarily mean the first assessment was careless; early illness is often nonspecific. What matters is that the safety plan continues while the diagnosis is clarified. Ask which symptoms should trigger return before results are available, and who will contact you with any result that changes care. [10]
Malaria is another important cause of fever after travel and requires rapid diagnosis and treatment. Symptoms may occur well after a trip, so do not limit your travel history to the previous few days. Tell the clinician all relevant destinations and dates, including stopovers or visits to friends and relatives. If you took malaria prevention medicine, mention its name and whether any doses were missed; taking it is not a reason to dismiss a new fever. Sly Academy’s guide to malaria treatment and urgent assessment explains why suspected malaria is a separate clinical concern. Do not choose between malaria and dengue yourself because one sounds more likely online. Seek assessment promptly while travelling or after returning, rather than waiting for a characteristic rash or a particular fever pattern to appear. [11]
Dengue testing: the illness day matters
A dengue test is not one interchangeable test that works equally well throughout illness. During the first seven days after symptoms begin, CDC recommends a molecular test such as RT-PCR together with IgM antibody testing, or an NS1 antigen test together with IgM. After day seven, IgM becomes the principal test in the CDC approach. A sample taken later may be needed if the early combination is negative or no early sample was collected. Care should start on clinical grounds when appropriate and should not wait for a laboratory result. For an appointment, write down the date the first symptoms appeared, not just the date of the first blood draw. This simple distinction helps the clinician interpret a result and choose the next step. A test ordered on the wrong assumptions about timing may answer a different question from the one the patient expects. [12]
Molecular tests look for dengue viral genetic material. A positive result can confirm the infection, while a negative result does not exclude it. Detection is generally most useful in the first week; fewer cases are detected by this method later. The result therefore needs to be read alongside the sample date and accompanying antibody tests. Ask for the actual name of the test rather than referring to every blood investigation as a dengue screen. If the report says PCR negative, ask whether IgM was also tested and whether a convalescent sample is planned. Keep the laboratory report rather than only a message saying negative. It may contain the collection date, test method, and interpretation that the next clinician needs. Do not treat repeat testing as permission to remain at home with new warning signs; the review plan and emergency plan are separate. [13]
NS1 testing looks for a dengue virus protein in blood and is especially useful during the first seven days of illness. A positive result supports a confirmed dengue infection, but it does not tell you which dengue serotype caused it. A negative NS1 result does not rule dengue out. Combining NS1 with IgM can detect infections that one test alone misses, and later testing may still be needed. Commercial tests also differ in how they have been evaluated and approved. For example, CDC states that the NS1 ELISA is the antigen test approved by the United States FDA for diagnostic use, while rapid NS1 products do not all have the same validation. That United States regulatory statement is not a claim about every country’s approvals. Ask the local treating service which test it uses and how it interprets that particular result. [14]
Antibody tests answer a different question from PCR or NS1. IgM usually becomes detectable several days into symptoms and can remain detectable for about three months. A positive IgM result from one sample is generally interpreted as evidence of a presumptive recent infection, not a precise date stamp. Antibodies to related viruses can complicate interpretation, and sometimes a laboratory needs additional testing. A negative antibody result very early in illness can be misleading because the immune response has not yet become detectable. A single IgG result is not a reliable way to diagnose an acute dengue episode; it may reflect past exposure. If you see words such as equivocal or indeterminate, ask what follow-up is recommended rather than deciding that they mean positive or negative. Bring previous laboratory reports when available so the clinician can distinguish a new illness from old test findings. [15]
What safe treatment actually involves
There is no specific antiviral medicine that routinely cures dengue. Clinical care is supportive and depends on stability, warning signs, hydration, other conditions, and access to review. CDC recommends hospital management for patients with warning signs and for certain higher-risk situations, including pregnancy. Some patients without warning signs can be managed outside hospital if they can drink, have adequate urine output, are stable, and have suitable follow-up. Daily or otherwise clinically indicated reassessment may be needed. Intravenous fluids are not automatically necessary, and routine preventive platelet transfusions or corticosteroids are not recommended. A clinician decides whether blood products are justified by the full situation, especially bleeding, rather than by one number in isolation. If the person lives alone or cannot easily reach care, say so: practical access problems can change what is safe. [16]
For a person a clinician has judged suitable for home care, the priorities are rest, appropriate fluids, symptom relief, and a clear plan for reassessment. CDC advises acetaminophen, called paracetamol in many countries, for fever or pain and warns against aspirin and ibuprofen. These medicines do not eliminate the virus. An improvement after a painkiller does not establish that the illness is mild or that follow-up can be skipped. Record what was taken and when, and bring the packaging if the ingredient is uncertain. Continue watching for warning signs as fever goes away. A supportive household plan should make it easier to follow medical advice, not compete with it. If symptoms worsen, use the return instructions rather than adding medicines or trying several new remedies while waiting to see what works. [17]
Use paracetamol carefully, not automatically
Follow the dose and timing on the specific paracetamol product or the personal instructions from a clinician. Strengths differ, and some people need a lower dose or extra advice because of factors such as low body weight, liver or kidney problems, or other medicines. Do not combine it with a cold-and-flu product that also contains paracetamol. Counting tablets without checking their strength is unsafe, and switching brands does not reset the amount already taken. A written medication record is especially helpful when more than one person is caring for the patient. If more than the recommended amount has been taken, seek medical advice promptly even if the person initially feels well. Do not use this article to calculate a maximum dose for someone with dengue-related organ problems; that needs individual guidance. [18]
Children need a child-appropriate preparation and dose based on the product instructions, age, and sometimes weight. A spoon from the kitchen is not a dependable medicine measure; use the measuring device supplied with the medicine. Different liquid strengths can contain different amounts in the same volume, so keep the bottle and instructions together. Ask a pharmacist or clinician if a child spits out or vomits a dose rather than automatically giving another full dose. General childhood fever guidance sometimes mentions ibuprofen, but suspected dengue is a specific reason to avoid it unless the treating clinician has explicitly resolved that concern. Do not give adult tablets or alternate products simply because the temperature remains high. A child who is deteriorating needs reassessment, not an escalating sequence of fever medicines. [19]
Hydration means an individualized plan, not forced drinking
Fever, vomiting, and poor intake can contribute to dehydration. Helpful observations include whether the person is drinking less, passing less urine, becoming dizzy, or developing a dry mouth. In babies, fewer wet nappies, reduced tears, or a sunken soft spot can be concerning. Small, frequent sips may be easier than a large drink when someone feels nauseated, and a pharmacist or clinician can advise on a suitable oral rehydration product when appropriate. Mix a recommended solution exactly as directed; do not improvise a concentrated version. Persistent vomiting, inability to keep fluids down, worsening drowsiness, or breathing difficulty requires medical assessment rather than a home target to be forced through. Someone with a prescribed fluid restriction needs personalized advice. This guide intentionally does not give a universal litres-per-day target or an intravenous fluid formula. [20]
Before leaving a clinic, ask the team to make the fluid instructions concrete for the person in front of them. Useful questions include which drinks are appropriate, how to recognize inadequate intake, what to do if vomiting starts, and whether any existing restriction still applies. Write the answers alongside the next review time. If several relatives are helping, choose one shared record rather than several conflicting estimates. It can show when drinks were offered, whether they stayed down, and when urine was last passed. The purpose is to give the clinician a clearer history, not to turn home care into a mathematical test. If a warning sign appears, the record can travel with the patient; finishing it is never more important than getting help.
Pregnancy, babies, and people who need extra support
Pregnancy deserves early contact with the maternity and medical teams when dengue is suspected. CDC describes possible transmission to the fetus during pregnancy or around birth and potential adverse outcomes, including premature birth and low birth weight. These are possible risks, not predictions for an individual pregnancy. Tell the clinician the gestational stage and whether symptoms began close to delivery. If the mother was ill near birth, the baby’s team also needs that information even if the newborn initially seems well. Newborn symptoms can vary and may emerge after delivery. Do not manage this situation by applying an adult home-care checklist to both mother and baby. Ask who is coordinating the care, what monitoring is needed, and whom to call if either patient changes overnight. [21]
Dengue in an infant may resemble other childhood infections and can be hard to recognize. Reduced wet nappies, a dry mouth, few tears, unusual sleepiness, marked irritability, or cool and discoloured hands and feet deserve prompt attention. Contact the child’s clinician immediately if dehydration is suspected; severe signs require urgent care. A parent’s observation that the baby is not behaving normally is important information even when there is no dramatic rash. Ask for age-appropriate feeding and fluid advice rather than copying an adult drinks plan. Keep protecting the infant from mosquito bites during illness, using appropriate physical barriers and products suitable for the child. A very young baby with fever needs clinical assessment; a home dengue test or a relative’s previous experience cannot decide whether it is safe to watch and wait. [22]
Older adults, people with chronic health conditions, and anyone who needs assistance obtaining drinks or transport may need a more supported plan. Before deciding that a relative can stay at home, discuss what support is actually available during the night as well as the day. Who can notice a change? Is a phone working and charged? Can the patient reach a bathroom safely? Is transport available if the clinic asks them to return? These are planning questions, not a severity score. Write down the service’s advice and do not assume that an apparently comfortable person living alone has the same options as someone with reliable help. If the planned support falls through, contact the treating service so the plan can be reconsidered.
Recovery: improvement is a trend, not a deadline
Most people recover over roughly one to two weeks, but tiredness can continue for several weeks after dengue. Recovery is not a contest to resume every normal activity as soon as the fever stops. Follow the clinician’s advice about follow-up and returning to work, school, exercise, or travel, especially after severe illness. New or worsening symptoms should not be dismissed as ordinary fatigue. A useful recovery conversation separates what is gradually improving from what is new: appetite, ability to drink, alertness, daily activity, and any breathlessness or bleeding. If progress is slower than expected, ask for reassessment rather than assuming that all lingering symptoms must be dengue. The goal is a safe return to ordinary life, not reaching a particular platelet number or copying another person’s recovery timeline. [1]
Prepare for the follow-up appointment by putting results in date order and keeping the symptom-onset date visible at the top. Write a brief account of what changed since the last review. For example, note that vomiting began after the visit, rather than saying only that the patient still feels ill. Ask whether another examination or blood test is needed and what decision that test will inform. If someone else attends the appointment, agree beforehand which questions matter most so that essential concerns are not lost. This approach is especially useful when care moves between a travel clinic, emergency department, and usual doctor. A concise timeline helps the next professional understand the sequence without relying on memory during a stressful conversation.
Prevent mosquito bites during illness and after travel
Protecting the sick person from mosquito bites also helps protect others. During the early illness, mosquitoes can acquire the virus from an infected person and then contribute to local transmission. CDC advises travellers returning from an area with dengue risk to prevent bites for three weeks, even if they feel well, and to watch for symptoms after travel. Use screens or air-conditioned accommodation where possible and a suitable mosquito net when sleeping in an unscreened setting. Daytime sleep also needs protection. Pack prevention supplies before travel so there is no need to improvise while unwell. After returning, tell a clinician about a new fever and where you travelled. These measures do not replace care for the patient; they reduce opportunities for mosquitoes to connect one infection to the next. [23]
Use an effective repellent approved for the setting and follow its label. CDC lists ingredients including DEET, picaridin, and IR3535 among effective options and advises loose, long-sleeved clothing and trousers. When used as directed, EPA-registered repellents can be used during pregnancy and breastfeeding. Children need careful application: do not put repellent on their hands, eyes, mouth, broken skin, or irritated areas. An adult can apply it to their own hands before applying it to the child’s face. Follow age restrictions on the product; CDC advises against OLE or PMD products for children under three. Use netting over baby carriers or strollers as an additional physical barrier. Apply sunscreen first and repellent afterwards when both are needed, and reapply according to the repellent label rather than a universal timetable. [24]
A repellent label is more useful than a vague instruction to spray generously. It specifies the intended use and precautions. EPA advises applying only as directed, avoiding cuts and irritated skin, and not spraying directly at the face or inhaling the mist. Do not use sprays near food or in an enclosed space. Store products where children cannot reach them and do not let young children handle the container. Washing treated skin when protection is no longer needed is part of sensible use. If a product irritates the skin or you are unsure which preparation suits a baby or a medical condition, obtain professional advice. Keep the original container rather than decanting it into an unlabelled travel bottle, because the directions and ingredient information may be needed later. [25]
At home, look for small water-holding items as well as obvious pools. Once a week, empty and scrub, cover, turn over, or discard suitable containers such as plant saucers, buckets, toys, and unused outdoor items. Cover stored water securely. Check indoors too, including vases and other overlooked containers. Repair damaged window and door screens and avoid leaving doors propped open. Insecticide products must be used according to their labels; an indoor spray alone will not remove the breeding opportunities around a home. For a practical routine, assign a regular day and check the same areas together, then add new items after rain or household changes. If a container cannot safely be emptied or covered, ask the local mosquito-control service what is appropriate rather than adding an arbitrary chemical, particularly to water used by people or animals. [26]
Clothing and gear treated with permethrin can provide another layer of bite protection when used according to the product directions. Permethrin is not a skin repellent and should never be applied directly to skin. A treated item and a skin-applied product have different purposes, so check which one is in your hand before use. Nets should be intact and arranged so that they provide an effective physical barrier while someone rests. Prevention needs to cover both day and night because mosquito species have different biting patterns and exposure can occur at several times. Do not assume that being indoors, staying at a well-known hotel, or avoiding only dusk is sufficient. Plan layers that are realistic for the activity, such as clothing, appropriate repellent, and screened accommodation, instead of relying on a single habit. [27]
Be cautious about gadgets or products that imply effortless protection without explaining their evidence or limitations. EPA distinguishes registered repellents from devices such as sound-wave products for which it does not have the same safety and effectiveness evidence. Spatial repellents also have instructions about where they can be used, the area they cover, and conditions such as wind; they are not automatically suitable for an enclosed bedroom. A product that works around one table is not necessarily protecting a person walking elsewhere. Read the use setting as carefully as the ingredient list. The practical question is whether the product has been evaluated for the job you expect it to do and whether you can use it correctly. Do not abandon established bite precautions because an advertisement says a bracelet or electronic device makes them unnecessary. [28]
Travel risk and community prevention
Dengue risk varies within countries and over time. CDC’s country and regional information distinguishes frequent transmission from sporadic or uncertain risk and provides notices when activity is higher than expected. A map is a planning aid, not a guarantee that one neighbourhood is safe or a prediction that every visitor will be infected. Check advice close to departure and discuss the actual itinerary, accommodation, duration, and personal medical circumstances with a travel-health professional. A city visit can still involve exposure. Save relevant medical contacts and know how to obtain care at the destination before illness disrupts the plan. If you have had dengue before, bring that history into the conversation rather than assuming either that you are protected or that you must automatically cancel every future trip. [29]
Public health teams investigate dengue cases to understand whether infection was acquired during travel or locally and to guide mosquito control. Accurate travel dates and places where the person stayed can help that work. This does not mean families should publish someone’s medical details or identify neighbours as the source of infection. Cooperate with verified local health services through their usual channels and keep personal information private. Community action is most useful when it removes breeding opportunities and helps residents follow clear prevention advice. Older neighbours or people with limited mobility may need practical assistance with heavy containers or damaged screens. A household doing its own checks is valuable, but coordinated local work can address shared spaces and problems that one resident cannot safely solve alone. [30]
Dengue vaccines: eligibility and availability are local
Vaccination is not a universal substitute for mosquito precautions. WHO recommends programmatic use of Qdenga, also called TAK-003, for children aged six to sixteen in settings with high dengue transmission intensity, using two doses three months apart. That recommendation is not an instruction for every traveller or every child worldwide to receive it. Prior infection, destination, age, local authorization, and medical history affect the discussion. WHO does not recommend TAK-003 for pregnancy, breastfeeding, or specified immune-deficiency situations. It also does not prevent every dengue case. A travel-health or local vaccination service should assess eligibility and explain the current national guidance. Tell the service about pregnancy plans, breastfeeding, immune-suppressing medicines, and any earlier dengue diagnosis rather than assuming those details are irrelevant to a travel vaccine. [31]
Availability has changed, so older vaccine summaries can be misleading. As checked on 22 October 2026, CDC’s September 2026 guidance states that no dengue vaccines are currently available in the United States. Dengvaxia is no longer available there, and Qdenga is not available or recommended for United States use. This should not be generalized into a claim that no country offers dengue vaccination. Conversely, an authorization in another country does not establish eligibility or access where you live. Ask the local service which product, if any, is currently offered and what evidence of previous infection is required for that product and programme. Do not arrange a vaccine based only on a social-media post or an old age range copied from a discontinued programme. Continue bite prevention whether vaccination is available, suitable, or completed. [32]
A practical plan to take away
Before the next review, keep four things together: the symptom timeline, laboratory reports, medicine packaging or a current medicine list, and the clinic’s written instructions. Make sure another trusted person knows where these are if the patient becomes too unwell to explain. Ask the clinician to separate urgent return signs from questions that can wait for the planned appointment. This prevents a family from interpreting every uncertainty as an emergency while also avoiding delay when a genuine warning sign appears. If instructions conflict between services, ask the current treating team to clarify them rather than combining pieces into a new plan. The safest plan is one the patient and caregiver can actually explain back in their own words.
A useful final question is: “If the fever settles tonight but the patient seems worse, where should we go?” Have an answer before that situation arises. Agree on who will accompany the patient, how to contact the service, and what to bring. Keep the plan accessible on paper or a phone without depending on a login that only the sick person knows. Sly Academy’s explanation of purpura and bleeding spots provides related background on a skin finding, but it cannot determine whether a particular rash is dengue. Use educational reading to prepare better questions, not to postpone an examination. When the patient’s condition and an online reassurance disagree, act on the condition and seek professional help.
Sources
- WHO: Dengue
- CDC: Symptoms of Dengue and Testing
- NHS: Dengue
- CDC: Clinical Features of Dengue
- Singapore Government: Warning signs that dengue is getting worse
- Singapore Communicable Diseases Agency: Dengue
- CDC Yellow Book: Dengue
- CDC: How Dengue Spreads
- NSW Health: Dengue fact sheet
- WHO: Clinical management of arboviral diseases
- NHS: Malaria
- CDC: Clinical Testing Guidance for Dengue
- CDC: Molecular Tests for Dengue Virus
- CDC: NS1 Antigen Tests for Dengue Virus
- CDC: Serologic Tests for Dengue Virus
- CDC: Clinical Care of Dengue
- CDC: Manage Dengue
- NHS: Paracetamol for adults
- NHS: Paracetamol for children
- NHS: Dehydration
- CDC: Dengue During Pregnancy
- CDC: Manage Dengue in Infants
- CDC: Preventing Dengue
- CDC: Preventing Mosquito Bites
- EPA: Using Insect Repellents Safely and Effectively
- CDC: Mosquito Control at Home
- CDC Yellow Book: Mosquitoes, Ticks, and Other Arthropods
- EPA: What is an Insect Repellent?
- CDC: Areas with Risk of Dengue
- CDC: Public Health Considerations for Dengue
- WHO: Vaccines and immunization, Dengue
- CDC: Dengue Vaccines






